Drug intelligence / Profile preview

125I-tyr-3-octreotide

Development stage
Preclinical
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

**125I-tyr-3-octreotide** is a *radioiodinated analogue of the somatostatin receptor ligand octreotide*, specifically labeled with radioactive iodine-125 at the tyrosine-3 position. It is used primarily as a radiopharmaceutical tool for imaging and research purposes to detect and study somatostatin receptor-positive tumors, typically neuroendocrine tumors. Its mechanism of action is based on binding with high affinity to somatostatin receptors, particularly subtypes 2 and 5, allowing for the localization and characterization of tumors by imaging techniques. It is not used therapeutically for disease modification or symptom control but for diagnostic, localization, or research applications.

Other names
125I-octreotideradioiodinated octreotide[125I-Tyr3]-octreotide
02

Targets

SSTR2 (Somatostatin receptor type 2)SSTR5 (Somatostatin receptor 5)SSTR (Somatostatin receptors)

Beyond the preview

Go deeper on 125I-tyr-3-octreotide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 125I-tyr-3-octreotide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call